title: Is endoscopic papillary large balloon dilation safe for treating large CBD stones?
abstract: In recent years, endoscopic papillary large balloon dilation (EPLBD) with endoscopic sphincterotomy (EST) has been shown to be an effective technique for the removal of large or difficult common bile duct (CBD) stones, as an alternative to EST. Reviewing the literature published since 2003, it is understood that EPLBD has fewer associated overall complications than EST. Bleeding occurred less frequently with EPLBD than with EST. There was no significant difference in postendoscopic retrograde cholangiopancreatography pancreatitis or perforation. Recent accumulated results of EPLBD with or even without EST suggest that it is a safe and effective procedure for the removal of large or difficult bile duct stones without any additional risk of severe adverse events, when performed under appropriate guidelines. Since use of a larger balloon can tear the sphincter as well as the bile duct, possibly resulting in bleeding and perforation, a balloon size that is equal to or smaller in diameter than the diameter of the native distal bile duct is recommended. The maximum transverse diameter of the stone and the balloon-stone diameter ratio have a tendency to affect the success or failure of complete removal of stones by large balloon dilation to prevent adverse effects such as perforation and bleeding. One should take into account the size of the native bile duct, the size and burden of stones, the presence of stricture of distal bile duct, and the presence of the papilla in or adjacent to a diverticulum. Even though the results of EPLBD indicate that it is a relatively safe procedure in patients with common duct stones with a dilated CBD, the recommended guidelines should be followed strictly for the prevention of major adverse events such as bleeding and perforation.
authors.affiliation: Department of Internal Medicine, School of Medicine, Konkuk University, Seoul, Korea.
authors.forename: Chan Sup
authors.initials: CS
authors.lastname: Shim
authors.affiliation: Department of Internal Medicine, School of Medicine, Konkuk University, Seoul, Korea.
authors.forename: Ji Wan
authors.initials: JW
authors.lastname: Kim
authors.affiliation: Department of Internal Medicine, School of Medicine, Konkuk University, Seoul, Korea.
authors.forename: Tae Yoon
authors.initials: TY
authors.lastname: Lee
authors.affiliation: Department of Internal Medicine, School of Medicine, Konkuk University, Seoul, Korea.
authors.forename: Young Koog
authors.initials: YK
authors.lastname: Cheon
mesh_terms: D002760:Cholangiopancreatography, Endoscopic Retrograde / Q000009:adverse effects* / Q000295:instrumentation / Q000379:methods*; D042883:Choledocholithiasis / Q000601:surgery*; D004106:Dilatation / Q000009:adverse effects* / Q000295:instrumentation / Q000379:methods*; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D016717:Sphincterotomy, Endoscopic / Q000009:adverse effects* / Q000295:instrumentation / Q000379:methods*; D016896:Treatment Outcome